ATE90873T1 - Bunazosin oder seine salze enthaltende pharmazeutische zubereitungen zur perkutanen verabreichung. - Google Patents

Bunazosin oder seine salze enthaltende pharmazeutische zubereitungen zur perkutanen verabreichung.

Info

Publication number: ATE90873T1
Authority: AT; Austria
Prior art keywords: percutaneous administration; salts; pharmaceutical preparations; administration containing; bunazosin
Prior art date: 1988-11-11

Application number

AT89120888T

Other languages

English (en)

Inventor

Mitsuhiro Yoshida

Hiroyuki Fujimori

Hidenori Asakawa

Masayoshi Kasai

Masanori Kayano

Shigemitsu Osawa

Original Assignee

Eisai Co Ltd

Sansho Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-11

Filing date

1989-11-10

Publication date

1993-07-15

1989-11-10 Application filed by Eisai Co Ltd, Sansho Co filed Critical Eisai Co Ltd

1993-07-15 Application granted granted Critical

1993-07-15 Publication of ATE90873T1 publication Critical patent/ATE90873T1/de

Links

RHLJLALHBZGAFM-UHFFFAOYSA-N Bunazosinum Chemical compound C1CN(C(=O)CCC)CCCN1C1=NC(N)=C(C=C(OC)C(OC)=C2)C2=N1 RHLJLALHBZGAFM-UHFFFAOYSA-N 0.000 title abstract 2
229960002467 bunazosin Drugs 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
150000003903 lactic acid esters Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT89120888T 1988-11-11 1989-11-10 Bunazosin oder seine salze enthaltende pharmazeutische zubereitungen zur perkutanen verabreichung. ATE90873T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP63285428A JP2794022B2 (ja)	1988-11-11	1988-11-11	ブナゾシン或いはその塩類含有経皮適用製剤
EP89120888A EP0368339B1 (de)	1988-11-11	1989-11-10	Bunazosin oder seine Salze enthaltende pharmazeutische Zubereitungen zur perkutanen Verabreichung

Publications (1)

Publication Number	Publication Date
ATE90873T1 true ATE90873T1 (de)	1993-07-15

Family

ID=17691396

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89120888T ATE90873T1 (de)	1988-11-11	1989-11-10	Bunazosin oder seine salze enthaltende pharmazeutische zubereitungen zur perkutanen verabreichung.

Country Status (11)

Country	Link
US (1)	US5041437A (de)
EP (1)	EP0368339B1 (de)
JP (1)	JP2794022B2 (de)
AT (1)	ATE90873T1 (de)
AU (1)	AU615115B2 (de)
CA (1)	CA2001574A1 (de)
DE (1)	DE68907312T2 (de)
DK (1)	DK559989A (de)
ES (1)	ES2057064T3 (de)
FI (1)	FI92149C (de)
NO (1)	NO176082C (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993000873A1 (en) *	1991-07-03	1993-01-21	Sano Corporation	Composition and method for transdermal delivery of diclofenac
US5900250A (en) *	1992-05-13	1999-05-04	Alza Corporation	Monoglyceride/lactate ester permeation enhancer for oxybutnin
EP0721348B1 (de) *	1993-09-29	1999-09-01	Alza Corporation	Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
US5420106A (en) *	1994-03-22	1995-05-30	Bristol-Myers Squibb Company	Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5503843A (en) *	1994-04-22	1996-04-02	Flora Inc.	Transdermal delivery of alpha adrenoceptor blocking agents
GB2301878A (en) *	1995-06-06	1996-12-18	Hardware & Systems Patents Ltd	Ventilator:mounting
ES2261190T3 (es) †	1999-02-08	2006-11-16	Alza Corporation	Vehiculos viscosos no acuosos estables de fase unica y formulaciones que utilizan dichos vehiculos.
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7179483B2 (en)	2000-04-26	2007-02-20	Watson Pharmaceuticals, Inc.	Compositions and methods for transdermal oxybutynin therapy
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2007140416A2 (en)	2006-05-30	2007-12-06	Intarcia Therapeutics, Inc.	Two-piece, internal-channel osmotic delivery system flow modulator
PT2359808E (pt)	2006-08-09	2013-08-28	Intarcia Therapeutics Inc	Sistemas de entrega osmótica e montagens de pistão
ES2402172T3 (es)	2007-04-23	2013-04-29	Intarcia Therapeutics, Inc	Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
WO2009102467A2 (en)	2008-02-13	2009-08-20	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
EP3735944A1 (de)	2009-09-28	2020-11-11	Intarcia Therapeutics, Inc.	Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko)	2015-06-03	2024-03-22	인타르시아 세라퓨틱스 인코포레이티드	임플란트 배치 및 제거 시스템들
CN109310743A (zh)	2016-05-16	2019-02-05	因塔西亚制药公司	胰高血糖素受体选择性多肽及其使用方法
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
AU2018206539A1 (en)	2017-01-03	2019-07-18	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4377581A (en) *	1980-03-03	1983-03-22	Pfizer Inc.	Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
JPS58225009A (ja) *	1982-06-23	1983-12-27	Shionogi & Co Ltd	コルチコステロイド外用製剤
JPS6122512A (ja) *	1984-07-06	1986-01-31	ヤマハ株式会社	ワイヤハ−ネス製造システム用コネクタ−配置ヘッド
JPS6169721A (ja) *	1984-09-13	1986-04-10	Kao Corp	抗真菌組成物
US4925837A (en) *	1984-09-14	1990-05-15	Synthelabo	Pharmaceutical compositions
JPS61225122A (ja) *	1985-03-30	1986-10-06	Eisai Co Ltd	キナツオリン系化合物含有組成物
JPH0735332B2 (ja) *	1986-02-25	1995-04-19	久光製薬株式会社	外用クリ−ム製剤
JP2521091B2 (ja) *	1986-06-18	1996-07-31	日研化学株式会社	カテコ−ルアミン類の外用製剤
JPH0816066B2 (ja) *	1986-07-18	1996-02-21	エーザイ株式会社	持続性薬効製剤
US4766842A (en) *	1987-04-29	1988-08-30	Jon Long	Method and means for wave soldering of leads of an integrated circuit package

1988
- 1988-11-11 JP JP63285428A patent/JP2794022B2/ja not_active Expired - Fee Related
1989
- 1989-10-24 FI FI895045A patent/FI92149C/fi not_active IP Right Cessation
- 1989-10-26 CA CA002001574A patent/CA2001574A1/en not_active Abandoned
- 1989-10-27 AU AU43845/89A patent/AU615115B2/en not_active Ceased
- 1989-10-27 US US07/428,240 patent/US5041437A/en not_active Expired - Fee Related
- 1989-11-09 NO NO894465A patent/NO176082C/no unknown
- 1989-11-09 DK DK559989A patent/DK559989A/da not_active Application Discontinuation
- 1989-11-10 EP EP89120888A patent/EP0368339B1/de not_active Expired - Lifetime
- 1989-11-10 DE DE89120888T patent/DE68907312T2/de not_active Expired - Fee Related
- 1989-11-10 ES ES89120888T patent/ES2057064T3/es not_active Expired - Lifetime
- 1989-11-10 AT AT89120888T patent/ATE90873T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI92149C (fi)	1994-10-10
NO894465D0 (no)	1989-11-09
US5041437A (en)	1991-08-20
DE68907312D1 (de)	1993-07-29
EP0368339A2 (de)	1990-05-16
FI92149B (fi)	1994-06-30
NO176082C (no)	1995-02-01
ES2057064T3 (es)	1994-10-16
DE68907312T2 (de)	1993-11-25
JP2794022B2 (ja)	1998-09-03
NO176082B (no)	1994-10-24
AU4384589A (en)	1990-05-17
EP0368339A3 (en)	1990-12-19
FI895045A0 (fi)	1989-10-24
DK559989A (da)	1990-05-12
DK559989D0 (da)	1989-11-09
EP0368339B1 (de)	1993-06-23
NO894465L (no)	1990-05-14
AU615115B2 (en)	1991-09-19
JPH02131426A (ja)	1990-05-21
CA2001574A1 (en)	1990-05-11

Legal Events

Date	Code	Title	Description
1994-02-15	UEP	Publication of translation of european patent specification
1999-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE90873T1 (de)	1993-07-15	Bunazosin oder seine salze enthaltende pharmazeutische zubereitungen zur perkutanen verabreichung.
PT83474B (pt)	1989-02-28	Processo de preparacao de uma composicao farmaceutica compreendendo o acido -2(2-fluoro-4-bifenilil)propionico ou um seu sal farmaceuticamente aceitavel
KR940005267A (ko)	1994-03-21	경피투여용 기제
ATE94765T1 (de)	1993-10-15	Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
ATE206914T1 (de)	2001-11-15	Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen
BG50273A3 (en)	1992-06-15	Method for the preparation of esters of the 1- benzyl- 3- hydroxymethylinedazol
GB8812653D0 (en)	1988-06-29	Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
ATE135909T1 (de)	1996-04-15	Verfahren zur behandlung von akne
ATE62594T1 (de)	1991-05-15	Pharmazeutische oder kosmetische zusammensetzung mit gehalt an hydrochinon und kojisaeure in liposomen.
FR2559151B1 (fr)	1989-01-13	Derives de l'arginine et sels d'addition d'acides correspondants pharmaceutiquement acceptables et compositions pharmaceutiques les contenant
IL82639A0 (en)	1987-11-30	Transdermal pharmaceutical composition
IT1214658B (it)	1990-01-18	Esteri polisaccaridici e loro sali
DE68900693D1 (de)	1992-02-27	Pharmazeutische praeparate zur transdermalen applikation von heparin.
JPS5640607A (en)	1981-04-16	Drug composition
ATE79277T1 (de)	1992-08-15	Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids.
IT1203815B (it)	1989-02-23	Esteri polisaccaridici e loro sali
TH2032A (th)	1984-12-03	ส่วนผสมสารกระตุ้นเซล
GT198400063A (es)	1985-10-18	Formulacion en dos faces